Literature DB >> 12525379

Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis.

J A G van Roon1, K A F M Glaudemans, J W J Bijlsma, F P J G Lafeber.   

Abstract

BACKGROUND: A large number of activated T cells are found in the joints of patients with rheumatoid arthritis (RA). Interleukin 7 (IL7), a T cell growth factor and a regulator of Th1 and Th2 cytokine production, is produced by synoviocytes from patients with RA.
OBJECTIVE: To investigate the effect on proinflammatory cytokine production of synovial fluid mononuclear cells (SFMC) and the mechanism by which IL7 influences CD4+ T cell activity in patients with RA.
METHODS: In a cross sectional group of patients with RA, IL7 levels were compared with those of healthy controls and related to disease activity. The effect of IL7 on cytokine production was tested by RA SFMC and on SF CD4+ T cells in the presence of mononuclear cells (MC). Production of tumour necrosis factor alpha (TNF alpha), IL1 beta, interferon gamma (IFN gamma), and IL4 was measured by enzyme linked immunosorbent assay (ELISA) and by single cell FACS analysis. Expression of the IL7 receptor alpha chain on CD4+ T cells (essential for IL7 signalling) was assessed. Direct effects of IL7 on isolated synovial fluid (SF) CD4+ T cells were studied by cytokine analysis. By neutralisation of IL12 in MC cultures, indirect effects of IL7 on T cells through accessory cells were studied.
RESULTS: IL7 serum levels were higher in patients with RA than in healthy controls and correlated positively with C reactive protein levels. IL7 stimulated TNFalpha production by SFMC and very potently stimulated IFN gamma and TNF alpha production by SF CD4+ T cells. These effects were probably mediated through the IL7 receptor alpha chain, which was abundantly expressed on SF CD4+ T cells. Besides the direct stimulation of T cell cytokine production by IL7, its action was partly dependent on IL12, indicating that IL7 also stimulates accessory cell function, leading to T cell activation.
CONCLUSION: IL7 stimulates proinflammatory cytokine production of intra-articular CD4+ T cells and accessory cells from patients with RA. The correlation with measures of disease activity indicates that IL7 might substantially contribute to the perpetuation of Th1 and TNF alpha mediated proinflammatory responses in patients with RA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525379      PMCID: PMC1754424          DOI: 10.1136/ard.62.2.113

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

Review 1.  Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis.

Authors:  J A van Roon; F P Lafeber; J W Bijlsma
Journal:  Arthritis Rheum       Date:  2001-01

2.  Regulation of human cytotoxic T lymphocyte development by IL-7.

Authors:  C J Hickman; J A Crim; H S Mostowski; J P Siegel
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

3.  Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.

Authors:  C M Verhoef; J A van Roon; M E Vianen; J W Bijlsma; F P Lafeber
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

4.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

5.  A proinflammatory role for IL-18 in rheumatoid arthritis.

Authors:  J A Gracie; R J Forsey; W L Chan; A Gilmour; B P Leung; M R Greer; K Kennedy; R Carter; X Q Wei; D Xu; M Field; A Foulis; F Y Liew; I B McInnes
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis.

Authors:  C M Verhoef; J A Van Roon; M E Vianen; C A Glaudemans; F P Lafeber; J W Bijlsma
Journal:  Scand J Immunol       Date:  1999-10       Impact factor: 3.487

7.  Divergent T-cell cytokine patterns in inflammatory arthritis.

Authors:  A K Simon; E Seipelt; J Sieper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

8.  HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.

Authors:  B P Wordsworth; J S Lanchbury; L I Sakkas; K I Welsh; G S Panayi; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Interleukin 7 is a growth factor for mature human T cells.

Authors:  M Londei; A Verhoef; C Hawrylowicz; J Groves; P De Berardinis; M Feldmann
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

10.  Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes.

Authors:  M R Alderson; T W Tough; S F Ziegler; K H Grabstein
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  38 in total

1.  IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.

Authors:  C C Walline; S Kanakasabai; J J Bright
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

2.  Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.

Authors:  Howard A Kader; Velizar T Tchernev; Ebenezer Satyaraj; Serguei Lejnine; Gregory Kotler; Stephen F Kingsmore; Dhavalkumar D Patel
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

3.  IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.

Authors:  Yuhao Gao; Francesco Grassi; Michaela Robbie Ryan; Masakazu Terauchi; Karen Page; Xiaoying Yang; M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

Review 4.  Role of the immune system in postmenopausal bone loss.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  Curr Osteoporos Rep       Date:  2005-09       Impact factor: 5.096

5.  Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis.

Authors:  Sarah R Pickens; Nathan D Chamberlain; Michael V Volin; Richard M Pope; Nicholas E Talarico; Arthur M Mandelin; Shiva Shahrara
Journal:  Arthritis Rheum       Date:  2011-10

6.  Interleukin 7 receptor gene polymorphisms and haplotypes are associated with susceptibility to IgA nephropathy in Korean children.

Authors:  Won-Ho Hahn; Jin-Soon Suh; Hae-Jung Park; Byoung-Soo Cho
Journal:  Exp Ther Med       Date:  2011-07-21       Impact factor: 2.447

7.  Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.

Authors:  Joel A G van Roon; Sarita A Y Hartgring; Marion Wenting-van Wijk; Kim M G Jacobs; Paul-Peter Tak; Johannes W J Bijlsma; Floris P J G Lafeber
Journal:  Ann Rheum Dis       Date:  2006-12-21       Impact factor: 19.103

8.  IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens.

Authors:  Pratima Deshpande; Mary M Cavanagh; Sabine Le Saux; Karnail Singh; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

9.  Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function.

Authors:  Steve Gendron; Marc Boisvert; Nizar Chetoui; Fawzi Aoudjit
Journal:  Immunology       Date:  2008-05-13       Impact factor: 7.397

10.  Ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions increase levels of nitric oxide and matrix metalloproteinase-9 without a direct association between them.

Authors:  Hideaki Yamaguchi; Yumi Kidachi; Hironori Umetsu; Kazuo Ryoyama
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.